Spiegel, R J <br/><br/>
Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.  [electronic resource] 

 -  Cancer research  Jan 1982 
 - 354-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anthracenes--administration & dosage<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Leukopenia--chemically induced<br/>Male<br/>Middle Aged